On June 4, Humana rose 5.25% in regular trading, trading at $347.685/share, with trading volume of $128 million. The stock rallied as multiple investment banks issued upgraded price targets in quick succession.

Bernstein significantly raised its target price on Humana from $288 to $425, maintaining an Outperform rating. Truist lifted its target from $270 to $320 while maintaining a Hold rating, and Morgan Stanley raised its target from $217 to $249. Prior to the upgrades, Humana reaffirmed its full-year adjusted earnings guidance of at least $9 per share, ahead of the FactSet consensus estimate of $8.93, with senior management scheduled to meet investors throughout June.

The broader Managed Health Care sector rallied in tandem, with Centene up 6.18%, UnitedHealth up 5.72%, Molina Healthcare up 4.89%, Elevance Health up 4.34%, and Alignment Healthcare up 8.84%, reflecting broad sector strength that further supported Humana's advance.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)